Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
olanzapine alpha-1a adrenergic receptor small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.03 approved,investigational antagonist
olanzapine alpha-1b adrenergic receptor small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.07 approved,investigational antagonist
olanzapine beta adrenergic receptor small molecule NA drugbank Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational inhibitor
olanzapine beta adrenergic receptor small molecule NA drugbank Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational inhibitor
olanzapine beta adrenergic receptor small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.05 approved,investigational inhibitor
olanzapine muscarinic acetylcholine receptor m1 small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.05 approved,investigational antagonist
olanzapine muscarinic acetylcholine receptor m2 small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.06 approved,investigational antagonist
olanzapine muscarinic acetylcholine receptor m3 small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.05 approved,investigational antagonist
olanzapine muscarinic acetylcholine receptor m4 small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.08 approved,investigational antagonist
olanzapine d(1) dopamine receptor small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.05 approved,investigational antagonist
olanzapine dopamine d1 receptor small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.05 approved,investigational antagonist
olanzapine dopamine d2 receptor small molecule Successful target TTD , drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.22 approved,investigational antagonist
olanzapine dopamine d3 receptor small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.09 approved,investigational antagonist
olanzapine dopamine d4 receptor small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.09 approved,investigational antagonist
olanzapine d(1) dopamine receptor small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.12 approved,investigational antagonist
olanzapine dopamine d5 receptor small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.12 approved,investigational antagonist
olanzapine gaba(a) receptor benzodiazepine binding site small molecule NA drugbank Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational inhibitor
olanzapine gaba(a) receptor benzodiazepine binding site small molecule NA drugbank Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational inhibitor
olanzapine gaba(a) receptor benzodiazepine binding site small molecule NA drugbank Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational inhibitor
olanzapine gaba(a) receptor benzodiazepine binding site small molecule NA drugbank Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational inhibitor
olanzapine gaba(a) receptor benzodiazepine binding site small molecule NA drugbank Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational inhibitor
olanzapine gaba(a) receptor benzodiazepine binding site small molecule NA drugbank Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational inhibitor
olanzapine gaba(a) receptor benzodiazepine binding site small molecule NA drugbank Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 NA approved,investigational inhibitor
olanzapine histamine h1 receptor small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.06 approved,investigational antagonist
olanzapine 5-hydroxytryptamine receptor 1 small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.05 approved,investigational inhibitor
olanzapine 5-hydroxytryptamine receptor 1 small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.05 approved,investigational inhibitor,agonist
olanzapine 5-hydroxytryptamine receptor 1 small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.04 approved,investigational inhibitor
olanzapine 5-hydroxytryptamine receptor 1 small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.04 approved,investigational inhibitor,agonist
olanzapine 5-hydroxytryptamine receptor 1 small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.05 approved,investigational inhibitor
olanzapine 5-hydroxytryptamine receptor 1 small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.05 approved,investigational inhibitor,agonist
olanzapine 5-hydroxytryptamine receptor 1 small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.09 approved,investigational inhibitor,agonist
olanzapine 5-hydroxytryptamine receptor 1 small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.09 approved,investigational inhibitor
olanzapine 5-hydroxytryptamine receptor 1 small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.03 approved,investigational inhibitor,agonist
olanzapine 5-hydroxytryptamine receptor 2a small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.13 approved,investigational antagonist
olanzapine 5-hydroxytryptamine receptor 2c small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.26 approved,investigational antagonist
olanzapine 5-hydroxytryptamine receptor 3a small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.06 approved,investigational antagonist
olanzapine 5-hydroxytryptamine receptor 6 small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Abnormal behavior[MeSHID:D000066553]
Depressive disorder[MeSHID:D003866]
Bipolar Disorder[MeSHID:D001714]
Maintenance[MeSHID:D008283]
Ability[MeSHID:D001076]
Hallucinations[MeSHID:D006212]
Delusions[MeSHID:D003702]
Psychomotor Agitation[MeSHID:D011595]
Affect (mental function)[MeSHID:D000339]
Depressive Disorder
Treatment-Resistant[MeSHID:D061218]
Mental Depression[MeSHID:D003863]
Thinking
function[MeSHID:D013850]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.09 approved,investigational antagonist
click here to return to the previous page